Vivitrol

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2018
01220072018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
AIM To evaluate the efficacy of treatment of patients at risk of deprivation of parental rights due to alcohol dependence under… (More)
Is this relevant?
Review
2018
Review
2018
INTRODUCTION An extended-release injectable naltrexone suspension (Vivitrol®) was approved in USA in 2010 for the prevention of… (More)
Is this relevant?
2015
2015
BACKGROUND AND AIMS Relapse to addiction following incarceration is common. We estimated the feasibility and effectiveness of… (More)
Is this relevant?
2014
2014
The quality parameters of naltrexone microspheres based on the copolymer of lactic and glycolic acids (PLGA) were established as… (More)
  • figure 1
  • table 3
  • table 6
  • table 5
  • table 7
Is this relevant?
2013
2013
This article presents the results of a study of clinical features of the development and course of alcohol dependence in patients… (More)
Is this relevant?
2011
2011
In May, the drugdelivery specialist Alkermes announced it would merge with Elan Drug Technologies (EDT), the chemical formulation… (More)
Is this relevant?
2011
2011
In May, the drugdelivery specialist Alkermes announced it would merge with Elan Drug Technologies (EDT), the chemical formulation… (More)
Is this relevant?
2007
2007
While oral naltrexone has a demonstrated ability to decrease alcohol reinforcement, it also has pharmacotherapeutic limitations… (More)
  • table 1
Is this relevant?
Review
2007
Review
2007
Combining pharmacotherapy with psychosocial and behavioral interventions has helped improve the treatment of alcohol dependence… (More)
Is this relevant?